Email This Article

Headlines & Perspectives
Genentech's Rituxan Faces Stiff Competition
By Marc Lichtenfeld
09/19/06 - 07:53 AM EDT
The arthritis drug could face a threat in '07 from a promising cancer-fighting competitor.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,420.64 1,111.82 2,200.99 33.58
Oil *
78.68
UP
150.17
UP
18.34
UP
33.11
DOWN
0.71
10 Yr
3.36%
SPDR Gold
111.30
+1.46%
+1.68%
+1.53%
-2.07%
Data delayed 20 minutes

Brokerage Partners